Caris Life Sciences, Inc. (CAI) stock
CAINasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/3078% above fair value
$17.58−0.96 (-5.18%)
Close on Nov 20, 2026Market cap $4.97BP/E –Yield –
Caris Life Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
No gross profit figures for Caris Life Sciences
Caris Life Sciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?